Annual Report for 30th Annual General Meeting to be held on 30th September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Boston Bio Systems Limited has submitted its Annual Report for FY 2024-25 along with the notice for its 30th Annual General Meeting to be held on September 30, 2025 via video conferencing. The AGM agenda includes adoption of audited financials, appointment of directors, and a proposed change of company name from 'Boston Bio Systems Limited' to 'Boston Commerce Limited'. The company is also seeking shareholder approval to drastically widen its business objects to cover IT/software, agriculture, real estate, e-commerce and general trading — a major pivot away from its existing bio-systems focus. Statutory auditor M/s Nahar V. & Co has resigned, and M/s Sunit M Chhatbar & Co is being appointed to fill the casual vacancy and also reappointed for a 5-year term. The board is additionally seeking approval to raise borrowing limits up to Rs. 50 crores and to authorize loans/investments under Section 186 up to the same limit.
Shareholders should note this AGM carries significant strategic decisions: a complete business pivot, a name change, an auditor change, and a sharp increase in permitted borrowings. The combination suggests the company is repositioning itself, and the auditor switch in particular warrants closer review of the audit report before the AGM.